Varicella Vaccine Potency and Stability During Transport and Delivery-Reference-Cited by-同舟云学术

Varicella Vaccine Potency and Stability During Transport and Delivery

Published:2011 Issue:2 Volume:85 Page:161-165
ISSN:0387-5911
Container-title:Kansenshogaku Zasshi
language:en
Short-container-title:J. J. A. Inf. D

Author:

KAMIYA Hitoshi¹,ASANO Yoshizo²,OZAKI Takao³,BABA koichi⁴,KUMAGAI Takuji⁵,NAGAI Takao⁶,SHIRAKI Kimiyasu⁷

Affiliation:

1. National Mie Hospital

2. Department of Pediatrics, Fujita Health University

3. Department of Pediatrics, Konan Kosei Hospital

4. Baba Pediatric Clinic

5. Kumagai Pediatric Clinic

6. Nagai Pediatric Clinic

7. Department of Virology, University of Tyama

Publisher

The Japanese Association for Infectious Diseases

Subject

General Medicine

Reference3 articles.

1. 1) Asano Y, Takahashi M：Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster. Biken J 1978；21（1）：15―23.

2. 4) Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al.：A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005；352 (22)：2271―84

3. 5) VARIVAX^Ⓡ Varicella Virus Vaccine Live, Whitehouse Station NJ08889, U.S.A. : http://www.merck.com/product/usa/pi_circulars/v/varivax/varivax_pi.pdf#search=ʼvarivaxʼ.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective cohort study evaluating the incidence of herpes zoster and postherpetic neuralgia after a live attenuated Oka-strain herpes zoster vaccine in a real-world setting in Japan;Vaccine;2024-01

2. Longitudinal changes in cell‐mediated immunity after varicella‐zoster virus skin test in the general population; Shozu Herpes Zoster Study: SHEZ study;Journal of Medical Virology;2022-12-08

3. Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review;Therapeutic Advances in Vaccines and Immunotherapy;2022-01

4. Changes in epidemiological characteristics and sero-prevalence against the varicella zoster virus in school-age children after the introduction of a national immunization program in Japan;Human Vaccines & Immunotherapeutics;2021-03-02

5. Cost-effectiveness of Recombinant Zoster Vaccine (RZV) and Varicella Vaccine Live (VVL) against herpes zoster and post-herpetic neuralgia among adults aged 65 and over in Japan;Vaccine;2019-06